missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Perindopril tert-Butylamine, Mikromol™
Description
Perindopril tert-Butylamine
Specifications
Specifications
| Chemical Name or Material | Perindopril tert-Butylamine |
| CAS | 107133-36-8 |
| Analyte or Component Names | Perindopril tert-Butylamine |
| Shipping Condition | Room Temperature |
| Molecular Formula | C19 H32 N2 O5 . C4 H11 N |
| Certifications/Compliance | ISO 17034 |
| Synonym | Perindopril tert-butylamine, 2-Methylpropan-2-amine (2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)butyl]amino]propanoyl]octahydro-1H-indole-2-carboxylate, 2-Methyl-2-propanamine (2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)butyl]amino]-1-oxopropyl]octahydro-1H-indole-2-carboxylate, Aceon, Butylaminiperindopril, Conversyl, Coversum, Coversyl, McN-A 2833-109, Perigard, Perindopril erbumine, Perindopril tert-butylamine salt, Perindopril-tert-butylamine, Perinodopril, Perinodpril erbimune, Prestarium, Procaptan, S 9490-3, [2S-[1[R*(R*)],2alpha,3abeta,7abeta]]-1-[2-[[1-(Ethoxycarbonyl)butyl]amino]-1-oxopropyl]octahydro-1H-indole-2-carboxylic acid compd. with 2-methyl-2-propanamine (1:1), 2-Methyl-2-propanamine [2S-[1[R*(R*)],2alpha,3abeta,7abeta]]-1-[2-[[1-(ethoxycarbonyl)butyl]amino]-1-oxopropyl]octahydro-1H-indole-2-carboxylate |
| InChI Formula | InChI=1S/C19H32N2O5.C4H11N/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24;1-4(2,3)5/h12-16,20H,4-11H2,1-3H3,(H,23,24);5H2,1-3H3/t12-,13-,14-,15-,16-;/m0./s1 |
| SMILES | CCC[C@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O)C(=O)OCC.CC(C)(C)N |
| IUPAC Name | (2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid;2-methylpropan-2-amine |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?